Protai raises $8 million in Seed for its proteomics-based platform for drug discovery
The company has developed an end-to-end AI-based platform that can map the course of a disease on the protein level
Source: calcalistech.com
Stay updated with breaking news from Avi Maayan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company has developed an end-to-end AI-based platform that can map the course of a disease on the protein level